The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer
Abstract
PURPOSE: The purpose of this article is to provide an overview of the current clinical status and possible future applications of aromatase inhibitors in breast cancer. METHODS: A review of the literature on the third-generation aromatase inhibitors was conducted. Some data that have been presented but not published are included. In addition, the designs of ongoing trials with aromatase inhibitors are outlined and the implications of possible results discussed. RESULTS: All of the third-generation oral aromatase inhibitors—letrozole, anastrozole, and vorozole (nonsteroidal, type II) and exemestane (steroidal, type I)—have now been tested in phase III trials as second-line treatment of postmenopausal hormone-dependent breast cancer. They have shown clear superiority compared with the conventional therapies and are therefore considered established second-line hormonal agents. Currently, they are being tested as first-line therapy in the metastatic, adjuvant, and neoadjuvant settings. Preliminary results suggest that the inhibitors might displace tamoxifen as first-line treatment, but further studies are needed to determine this. CONCLUSION: The role of aromatase inhibitors in premenopausal breast cancer and in combination with chemotherapy and other anticancer treatments are areas of future exploration. The ongoing adjuvant trials will provide important data on the long-term safety of aromatase inhibitors, which will help to determine their suitability for use as chemopreventives in healthy women at risk of developing breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Boyd, N. F., Byng, J. W., Jong, R. A., Fishell, E. K., Little, L. E., Miller, A. B., Lockwood, G. A., Tritchler, D. L., & Yaffe, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.670 · Cited by 1,105
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638
Kaufmann, M., Bajetta, E., Dirix, L. Y., Fein, L. E., Jones, S. E., Zilembo, N., Dugardyn, J.-L., Nasurdi, C., Mennel, R. G., Cervek, J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1399 · Cited by 521
Is Estradiol a Genotoxic Mutagenic Carcinogen?1
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0386 · Cited by 484
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Dauvois, S., Danielian, P. S., White, R., & Parker, M. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4037 · Cited by 465
Buzdar, A. U., Jonat, W., Howell, A., Jones, S. E., BLOMQVIST, C. P., Vogel, C. L., EIERMANN, W., Wolter, J. M., Steinberg, M., Webster, A., et al. (1998) · PubMed · Cited by 417
(1988) · PubMed · Cited by 416
Buzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2000 · Cited by 406
Bulun, S. E., Price, T. M., Aitken, J., Mahendroo, M. S., & Simpson, E. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8117355 · Cited by 335
Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2234 · Cited by 316
Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314
The importance of local synthesis of estrogen within the breast
Miller, W. R., & O'Neill, J. (1987) · Steroids · doi:10.1016/0039-128x(87)90037-7 · Cited by 280
Experimentally induced mammary tumors in rats
Russo, J., & Russo, I. H. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806074 · Cited by 267
Gershanovich, M., Chaudri, H. A., Campos, D., Lurie, H., Bonaventura, A., Jeffrey, M., Buzzi, F., Bodrogi, I., Ludwig, H., Reichardt, P., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008226721932 · Cited by 259
Jonat, W., Howell, A., Blomqvist, C., Eiermann, W., Winblad, G., Tyrrell, C., Mauriac, L., Roche, H., Lundgren, S., Hellmund, R., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00014-3 · Cited by 254
Bhatnagar, A. S., Häusler, A., Schieweck, K., Lang, M., & Bowman, R. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90460-3 · Cited by 246
Is Estradiol a Genotoxic Mutagenic Carcinogen?
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.40 · Cited by 235
Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies
James, V. H. T., McNeill, J. M., Lai, L. C., Newton, C. J., Ghilchik, M. W., & Reed, M. J. (1987) · Steroids · doi:10.1016/0039-128x(83)90077-6 · Cited by 219
Buzdar, A. U., Jones, S. E., Vogel, C. L., Wolter, J., Plourde, P., Webster, A., & for the Arimidex Study Group (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<730::aid-cncr10>3.0.co;2-0 · Cited by 207
Arimidex Study Group, Buzdar, A. U., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C. P., Vogel, C. L., Eiermann, W., Wolter, J. M., Steinberg, M., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1142::aid-cncr13>3.0.co;2-5 · Cited by 174
Concentration of Sex Steroids in Adipose Tissue after Menopause
Szymczak, J., Milewicz, A., Thijssen, J. H. H., Blankenstein, M. A., & Daroszewski, J. (1998) · Steroids · doi:10.1016/s0039-128x(98)00019-1 · Cited by 169
Vanderschueren, D., Herck, E. V., Nijs, J., EDERVEEN, A. G. H., Coster, R. D., & Bouillon, R. (1997) · Endocrinology · doi:10.1210/endo.138.6.5216 · Cited by 163
Yue, W., Zhou, D., Chen, S., & Brodie, A. (1994) · PubMed · Cited by 157
Aberrant Expression of Aromatase in Breast Cancer Tissues
Harada, N. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80010-6 · Cited by 154
Thurlimann, B. J. K., Paridaens, R., Serin, D., Bonneterre, J. M., Roche, H. H., Murray, R., di Salle, E., Lanzalone, S., Zurlo, M. G., & Piscitelli, G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00283-9 · Cited by 141
Biological Significance of Aromatase Activity in Human Breast Tumors*
Tilsen-Mallett, N., Santner, S. J., Feil, P. D., & Santen, R. J. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1125 · Cited by 140
Resistance of the Ovary to Blockade of Aromatization with Aminoglutethimide*
Santen, R. J., SAMOJLIK, E., & Wells, S. A. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-473 · Cited by 129
Oestradiol synthesis from C19 steroids by human breast cancers
Miller, W. R., & Forrest, A. P. M. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.13 · Cited by 123
Jones, S., Vogel, C. L., Arkhipov, A., Fehrenbacher, L., Eisenberg, P. D., Cooper, B., Honig, S. F., Polli, A., Whaley, F. S., di Salle, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3418 · Cited by 118
Hamilton, A. L., & Piccart, M. J. (1999) · Annals of Oncology · doi:10.1023/a:1008368300827 · Cited by 118
Buzdar, A. U., Smith, R. A., Vogel, C. L., Bonomi, P., Keller, A. M., Favis, G., Mulagha, M. T., Cooper, J., & for the Multi-Institutional Trialist Collaborative Study Group (1996) · Cancer · Cited by 118
TEKMAL, R. R., Ramachandra, N., Gubba, S., Durgam, V. R., Mantione, J. R., Toda, K., Shizuta, Y., & Dillehay, D. L. (1996) · PubMed · Cited by 113
Studies on the mechanism of estrogen biosynthesis in the rat ovary–I
Brodie, A. M. H., Schwarzel, W. C., & Brodie, H. J. (1976) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(76)90180-1 · Cited by 112
Goss, P. E., Winer, E. P., Tannock, I. F., & Grou, L. H. S. O. B. O. T. N. A. V. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.52 · Cited by 111
Self-citationRelationship between tumour aromatase activity, tumour characteristics and response to therapy
Miller, W. R., Anderson, T. J., & Jack, W. J. L. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90465-w · Cited by 108
Regulation of Aromatase Activity Within the Breast
Miller, W. R., Mullen, P., Sourdaine, P., Watson, C. J. E., Dixon, J. M., & Telford, J. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80012-x · Cited by 105
Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer
Harris, A. L., Dowsett, M., Jeffcoate, S. L., McKinna, J. A., Morgan, M., & Smith, I. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-718 · Cited by 99
Examination ofPOU homeobox gene expression in human breast cancer cells
Jin, T., Branch, D. R., Zhang, X., Qi, S., Youngson, B. J., & Goss, P. (1999) · International Journal of Cancer · Cited by 99
Self-citationStein, R. C., Dowsett, M., Hedley, A., Gazet, J. C., Ford, H., & Coombes, R. C. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.356 · Cited by 96
Thurlimann, B. J. K., Beretta, K., Bacchi, M., Castiglione‐Gertsch, M., Goldhirsch, A., Jungi, W. F., Cavalli, F., Senn, H.-J., Fey, M. F., & Löhnert, T. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010635 · Cited by 95
Smith, I. E., Harris, A. L., Morgan, M., Gazet, J. C., & McKinna, J. A. (1982) · PubMed · Cited by 92
Pharmacology of new aromatase inhibitors
Lønning, P. E. (1996) · The Breast · doi:10.1016/s0960-9776(96)90094-6 · Cited by 92
Schieweck, K., Bhatnagar, A. S., & Matter, A. (1988) · PubMed · Cited by 90
Dowsett, M., Pfister, C. U., Johnston, S. R. D., Miles, D. W., Houston, S. J., Verbeek, J. A., Gundacker, H. M., Sioufi, A., & Smith, I. E. (1999) · PubMed · Cited by 90
Aromatization of androgens is important for skeletal maintenance of aged male rats
Vanderschueren, D., Herck, E. V., Coster, R. D., & Bouillon, R. (1996) · Calcified Tissue International · doi:10.1007/s002239900106 · Cited by 87
Dowsett, M., Stein, R. C., & Coombes, R. C. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90201-s · Cited by 81
Murray, R., & Pitt, P. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665976 · Cited by 80
Aromatase inhibitors ? mechanisms of steroidal inhibitors
Brueggemeier, R. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682739 · Cited by 75
Aromatase inhibitors and their antitumor effects in model systems.
Brodie, A., Lü, Q., Liu, Y., & Long, B. J. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060205 · Cited by 75
The effects of aromatase inhibitors and antiestrogens in the nude mouse model
Lü, Q., Yue, W., Wang, J., Liu, Y., Long, B. J., & Brodie, A. M. H. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006004930930 · Cited by 72
Current perspectives on aromatase inhibitors in breast cancer.
Goss, P. E., & Gwyn, K. M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2460 · Cited by 70
Self-citationAromatase inhibitors ? mechanisms for non-steroidal inhibitors
BOSSCHE, H. V., Moereels, H., & Koymans, L. M. H. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682740 · Cited by 70
Breast tumor aromatase: functional role and transcriptional regulation.
Chen, S., Zhou, D., Okubo, T., Kao, Y., & Yang, C. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060149 · Cited by 70
TEKMAL, R. R., Kirma, N. B., Gill, K., & Fowler, K. A. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060307 · Cited by 66
Lubet, R. A., Steele, V. E., Casebolt, T. L., Eto, I., Kelloff, G. J., & Grubbs, C. J. (1994) · Carcinogenesis · doi:10.1093/carcin/15.12.2775 · Cited by 62
Ingle, J. N., Suman, V. J., JOHNSON, P. A., Krook, J. E., Mailliard, J. A., Wheeler, R. H., Loprinzi, C. L., Perez, E. A., Jordan, V. C., & Dowsett, M. (1999) · PubMed · Cited by 61
Ingle, J. N., Green, S., Ahmann, D. L., Long, H. J., Edmonson, J. H., Rubin, J., Chang, M. N., & Creagan, E. T. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.6.958 · Cited by 58
Schieweck, K., Bhatnagar, A. S., Batzl‐Hartmann, C., & LANG, M. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90270-7 · Cited by 55
Bolufer, P., Ricart, E., Lluch, A. M., Vazquez, C., Rodrı́guez, A., Ruíz, A., Llopis, F., García-Conde, J., & Romero, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.3.438 · Cited by 52
Dowsett, M., Doody, D., Miall, S., Howes, A. J., English, J., & Coombes, R. C. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006289811540 · Cited by 49
Dowsett, M., Tobias, J. S., Howell, A., Blackman, G., Welch, H., King, N. C., Ponzone, R., von Euler, M., & Baum, M. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690050 · Cited by 45
Harper-Wynne, C. L., & Coombes, R. C. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00015-5 · Cited by 43
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer
Wander, H. E., Blossey, H. C., & Nagel, G. A. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90147-1 · Cited by 41
Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
Brodie, A. M., Lü, Q., Liu, Y., Long, B. J., WANG, J.-P., & Yue, W. (1998) · PubMed · Cited by 41
Miller, W. R., Telford, J., Love, C. D. B., Leonard, R. C., Hillier, S. G., Gundacker, H. M., Smith, H., & Dixon, J. M. (1998) · The Breast · doi:10.1016/s0960-9776(98)90095-9 · Cited by 39
Alonso, M. C., Ojeda-González, M. B., Beltran-Fabregat, M., Ribugent, J. D., López-López, L., Borrás-Balada, J., Cardenal-Alemany, F., Gómez‐Batiste, X., Fabregat-Mayol, J., & Viladiu-Quemada, P. (2009) · Oncology · doi:10.1159/000226639 · Cited by 39
Characterization of a Silencer Element in the Human Aromatase Gene
Zhou, D., & Chen, S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0641 · Cited by 38
Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey, H. A., Lipton, A., White, D., Santen, R. J., Boucher, A. E., Shafik, A., & Dixon, R. (1982) · PubMed · Cited by 37
Coster, R. D., Ginckel, R. V., Callens, M., Goeminne, N., & Janssens, B. L. (1992) · PubMed · Cited by 36
Clinical use of aromatase inhibitors in human breast carcinoma
Santen, R. J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90189-c · Cited by 31
Russell, C. A., Green, S., O’Sullivan, J. M., Hynes, H. E., Budd, G. T., Congdon, J. E., Martino, S., & Osborne, C. K. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2494 · Cited by 23
Goss, P. E., Strasser, K., Marques, R. J., Clemons, M. J., Oza, A. M., Goel, R., Blackstein, M. E., Kaizer, L., Sterns, E. E., Nabholtz, J., et al. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006480504790 · Cited by 22
Self-citationMilsted, R., Habeshaw, T., Kaye, S. B., Sangster, G., Macbeth, F. R., Campbeli-Ferguson, J., Smith, D. C., & Calman, K. C. (1985) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00258132 · Cited by 22
Goss, P. E., Oza, A. M., Goel, R., Nabholtz, J., Coster, R. D., Bruynseels, J., Reid, C., Wadden, N. A. T., Crump, M., & Tye, L. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006320122711 · Cited by 21
Self-citationMiller, W. R., Telford, J., Love, C. D. B., Leonard, R. C., Hillier, S. G., Bischoff, M. A., Gundacker, H. M., & Dixon, J. M. (1997) · The Breast · doi:10.1016/s0960-9776(97)90593-2 · Cited by 5
Cited by
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Self-citationAwareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
Self-citationWiner, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Metadata
- Authors
- Goss, P. E., & Strasser, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-02-01
- Volume
- 19
- Issue
- 3
- Pages
- 881-894
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2128100826
- Cited by
- 298
- References
- 77
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.